Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · IEX Real-Time Price · USD
2.120
-0.020 (-0.93%)
At close: Jul 2, 2024, 4:00 PM
2.090
-0.030 (-1.42%)
After-hours: Jul 2, 2024, 7:59 PM EDT

Tempest Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 2012
Market Capitalization
478512364191
Upgrade
Market Cap Growth
254.12%600.22%-66.85%-10.26%-55.22%378.24%
Upgrade
Enterprise Value
3566332432
Upgrade
PE Ratio
--2.87-0.34-1.29-2.12-2.04
Upgrade
PB Ratio
2.283.160.671.01-0.591.55
Upgrade
P/FCF Ratio
-3.27-3.08-0.38-1.40-2.13-2.18
Upgrade
P/OCF Ratio
-3.31-3.10-0.39-1.41-2.14-2.20
Upgrade
EV/EBITDA Ratio
-2.85-2.55-0.09-0.12-1.31-0.73
Upgrade
EV/EBIT Ratio
-2.64-2.36-0.09-0.12-1.26-0.71
Upgrade
EV/FCF Ratio
-2.82-2.40-0.09-0.12-1.27-0.76
Upgrade
Debt / Equity Ratio
0.990.771.220.51-0.040.08
Upgrade
Debt / EBITDA Ratio
-0.78-0.80-0.69-0.72-0.13-0.10
Upgrade
Debt / FCF Ratio
-0.77-0.75-0.70-0.71-0.13-0.11
Upgrade
Quick Ratio
3.024.174.292.595.845.07
Upgrade
Current Ratio
3.134.294.533.446.155.68
Upgrade
Interest Coverage
-19.20-19.35-21.07-21.08--
Upgrade
Return on Equity (ROE)
-232.40%-283.90%-130.80%-74.10%-112.20%-82.50%
Upgrade
Return on Assets (ROA)
-79.00%-82.10%-57.70%-45.70%-39.00%-64.60%
Upgrade
Return on Capital (ROIC)
-72.07%-61.48%-86.12%-49.38%29.08%-72.31%
Upgrade
Earnings Yield
-63.18%-34.82%-295.25%-77.57%-47.24%-49.08%
Upgrade
FCF Yield
-56.33%-32.50%-261.55%-71.51%-46.89%-45.83%
Upgrade
Buyback Yield / Dilution
-61.55%-33.49%-204.70%-709.62%48.77%-785.99%
Upgrade
Total Shareholder Return
-61.55%-33.49%-204.70%-709.62%48.77%-785.99%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).